Recap: CytoSorbents Q3 Earnings
Portfolio Pulse from Benzinga Insights
CytoSorbents (NASDAQ:CTSO) reported Q3 earnings, missing estimated earnings by 75.0% with an EPS of $-0.21 versus an estimate of $-0.12. However, revenue was up $700 thousand from the same period last year. Last quarter, the company also missed on EPS by $0.03, which was followed by a 7.46% drop in the share price the next day.
November 09, 2023 | 9:50 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
CytoSorbents' Q3 earnings missed estimates significantly, which could potentially lead to a drop in share price, similar to the 7.46% drop observed last quarter after missing EPS estimates.
CytoSorbents' significant miss on Q3 earnings estimates could negatively impact investor sentiment and lead to a drop in share price. This is based on the observed trend from last quarter, where a miss on EPS estimates led to a 7.46% drop in share price the following day.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100